🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10453+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10453 recruiting trials

Phase 2RecruitingNCT06846489

Acalabrutinib Plus Rituximab for the Treatment of Elderly or Low- to Intermediate-Risk Younger Untreated Mantle Cell Lymphoma

🏥 Sun Yat-sen University📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06858813

A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)

👨‍⚕️ ABBVIE INC., AbbVie📍 22 sites📅 Started Apr 2025View details ↗
Phase 1, PHASE2RecruitingNCT06364774

ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia

👨‍⚕️ Janet Kwiatkowski, MD, Children's Hospital of Philadelphia📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06843330

Accuracy of Lactate Meter in GSDIa

🏥 Connecticut Children's Medical Center📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06925360

IVIG Trial for the Treatment of Bronchopulmonary Dysplasia

👨‍⚕️ Fu Xuemei, International Peace Maternity and Child Health Hospital📍 1 site📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT07187193

Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH

👨‍⚕️ Xinxin XX Cao, doctor, NCC, CICAMS📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06916624

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

🏥 The Affiliated Hospital of Qingdao University📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT06961864

Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

👨‍⚕️ Michael-Paul Schallmo, Ph.D., University of Minnesota, Department of Psychiatry and Behavioral Sciences📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06968975

Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)

🏥 Sanofi📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06878235

Validation of the French Version of the Primary Lateral Sclerosis Functioning Rating Scale (PLSFRS)

👨‍⚕️ Philippe CORCIA, PR, University Hospital, Tours📍 7 sites📅 Started Apr 2025View details ↗
NARecruitingNCT07248176

Universal CAR-T Cell Therapy for MM

👨‍⚕️ Ping Li, PhD, 13564181131📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT07234747

Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis

👨‍⚕️ Nilay Arman, Assoc. Prof. Dr., Istanbul University-Cerrahpaşa, Faculty of Health Science, Department of Physiotherapy and Rehabilitation, Istanbul, Türkiye📍 1 site📅 Started Apr 2025View details ↗
NARecruitingNCT07188311

Pucotenlimab Combined With Lenvatinib and Chemotherapy in the Treatment of Advanced, Relapsed/Refractory Hepatoblastoma in Children

🏥 Sun Yat-sen University📍 1 site📅 Started Apr 2025View details ↗
Phase 1RecruitingNCT06622005

SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

👨‍⚕️ Jens Hillengass, MD, Roswell Park📍 1 site📅 Started Apr 2025View details ↗
RecruitingNCT06806774

Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic Arthritis

👨‍⚕️ Sinan Buran, MSc, Hacettepe University Faculty of Physical Therapy and Rehabilitation📍 2 sites📅 Started Apr 2025View details ↗
Phase 3RecruitingNCT06846671

A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

👨‍⚕️ Study Director, BeOne Medicines📍 112 sites📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06702033

The Minimalist Trial-2

👨‍⚕️ Douglas Adkins, M.D., Washington University School of Medicine📍 1 site📅 Started Apr 2025View details ↗
Phase 1, PHASE2RecruitingNCT07022197

Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases

👨‍⚕️ Qiang Liu, M.D.,Ph.D, Tianjin Medical University General Hospital📍 1 site📅 Started Apr 2025View details ↗
Enrolling by InvitationNCT06860828

The DIAGNOSE CTE Research Project-II

👨‍⚕️ Michael Alosco, PhD, Boston University Alzheimer's Disease and CTE Center📍 5 sites📅 Started Apr 2025View details ↗
Phase 2RecruitingNCT06835530

A Combination of Rituximab and CC-99282 as Front-line Therapy for Older Frail Patients With Diffuse Large B-cells Non-Hodgkin Lymphoma Evaluated With a Simplified Geriatric Assessment (sGA): a Phase II Study of the Fondazione Italiana Linfomi (FIL)

👨‍⚕️ Alessandra Tucci, Dr.ssa, UO Ematologia, ASST Spedali Civili di Brescia, Piazzale Spedali Civili, 1, 25123 Brescia, Italia📍 20 sites📅 Started Apr 2025View details ↗
← PreviousPage 124 of 523Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →